By Bhavish Lekh, Co-founder & CEO

I still remember how long it took me to get my first job in clinical research.

I'd finished my BSc in Biochemistry, then my MSc in Clinical Research, and I spent a long time knocking on doors before anything opened. Quintiles, the company known today as IQVIA, gave me that first chance, and the rest was history: a career in feasibility, and eventually the decision to build Aurora Analytica. But I've never forgotten how it felt to be on the outside of an industry I desperately wanted to be part of.

There's a detail from that time I've come to appreciate more over the years. My MSc dissertation was a collaboration with clinical trial intelligence platforms, Citeline among them, assessing their capabilities and presenting the findings to Quintiles leadership with a recommendation on which to subscribe to and which capabilities could be internalised from public sources. Without realising it, I was already asking the question that would one day become Aurora Analytica: what should intelligence tools actually do for the people who use them?

I think about that feeling a lot right now, because entering our industry today is even harder than it was then. And layered on top of it is a question I hear in almost every conversation: with AI moving this fast, will there still be a place for people at all?

The stigma is real, and understandable

There's no point pretending otherwise: AI companies carry a stigma at the moment. People have watched restructurings and headlines and drawn a reasonable conclusion, which is that this technology is mostly being used to remove humans from the picture. The employment market is unsettled while industries work out what these tools mean, and behind every one of those headlines are people wondering where they fit.

I don't want to argue with anyone's worry, because I think it deserves a serious answer rather than a dismissal. The honest answer is that AI is a tool, and what it does to people's lives depends entirely on what the people building with it choose to do. This post is about the choice we've made.

The building and the pillars

Picture a building. The pillars are human: the expertise of people who have done this work for a living, the ethics clinical research demands, the judgement that comes from experience. AI is everything built on top of them, and the taller you want to build, the stronger those pillars need to be.

That is exactly how the Aurora Suite is built. The foundation is human expertise made into software: transparent, rule-based decision engines designed by people from clinical research, where every recommendation can be traced and explained. Starlite-AI, our AI layer, is being added on top in deliberate phases, each one bringing new functions and multiplying what a single person can deliver: more evidence assessed, more scenarios tested, more strategic options explored in a day than used to be possible in a week.

That's the part the replacement debate misses. Built this way, AI doesn't take work away from people. It raises the ceiling on what each person is capable of.

Why a human stays at the wheel

In clinical research, keeping people at the centre isn't just a preference. It reflects what this work is. Behind every trial there are patients waiting for answers, families hoping, and teams who carry a duty of care that has been at the heart of this industry for as long as it has existed. Decisions of that weight need a person behind them: someone who understands the responsibility, can explain the reasoning, and can stand behind the outcome.

That's not a limitation of the technology. Responsibility is not something you can automate, and I don't believe we should try. What we can do is take the heavy, repetitive work off people's desks, the data gathering and reconciling and manual preparation that eats the hours, so that human time goes where human judgement matters.

Room for the next generation

When I talk about humans and AI working together, I don't only mean people like me, with years in the industry behind them. I mean the new generation: the graduates and career-changers knocking on doors the way I once did, wanting to be part of clinical research.

If we build this technology well, it should open more of those doors, not close them. Tools that take away the drudgery make room for people to learn the parts of the job that actually matter, like the thinking, the strategy, and the care. Someone gave me a chance at the start of my career. I want the industry we're helping to build to still be one where chances like that exist.

A vision, honestly held

I won't claim to know how the AI era plays out. Nobody does, and I'm wary of anyone who says otherwise. What I can offer is a commitment: we will keep building with the human foundation first, we will apply AI positively and responsibly, and we will measure ourselves against whether the technology leaves a positive impact on the people it touches, in trials, in teams, and in society.

That's the approach. If it resonates with you, whether you'd like to work with us, become a customer, collaborate, or you're just finding your way into this industry, we'd love to hear from you. Get in touch through the contact form on our website.

Bhavish Lekh is the Co-founder and CEO of Aurora Analytica. Connect with him on LinkedIn.